Global Durvalumab Market Professional Research Report 2014-2026, Segmented by Players, Types, End-Users in Major 40 Countries or Regions

Jul 11, 2020 | 201 PAGES | REPORT CODE: CMM345750

REPORT SUMMARY
TABLE OF CONTENTS
INDUSTRY COVERAGE

The Durvalumab is expected to grow from USD XX.0 million in 2018 to USD XX.0 million by 2025, at a Compound Annual Growth Rate (CAGR) of 5.3% during the forecast period. The research provides insights for the global Durvalumab market based on different Types, End-Users and Regions, and competitive landscape of these segments are analyzed in detail.

A wide range of market influence factors are taken into consideration in the analysis, and potential developing factors for different Types, End-Users and Regions are also included in the report in order to figure out the most promising development trends in the Durvalumab industry. For presenting the most potential investment fields in North America, Europe, Asia Pacific and Latin America, Middle East & Africa, the market capacity and consumption potential of more than 34 major powers are covered in the research, providing valuable opinions of strategic adjustments for existing groups and new entrants.

The Snapshot of Global Durvalumab Market Segmentations:

By Players:

Medimmune (AstraZeneca)

By Types:

24mL Injection
10mL Injection

By End-User:

Locally Advanced Urothelial Carcinoma
Metastatic Urothelial Carcinoma
Other

By Regions:

North America

United States
Canada
Mexico

Europe

Germany
UK
France
Italy
Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden)
Spain
Belgium
Poland
Russia
Turkey
Others

Asia-Pacific

China
Japan
India
South Korea
Australia and New Zealand
ASEAN Countries (Indonesia, Thailand, Malaysia, Singapore, Philippines, Vietnam, Others)

Latin America, Middle East & Africa

GCC Countries (Saudi Arabia, United Arab Emirates, Qatar, Others)
Brazil
Nigeria
South Africa
Argentina
Others

Table of Contents

1 Report Overview

1.1 Product Definition and Scope
1.2 PEST (Political, Economic, Social and Technological) Analysis of Durvalumab Market
1.3 Market Segmentation by Type

1.3.1 Global Durvalumab Market Size and Growth Rate of 24mL Injection from 2014 to 2026
1.3.2 Global Durvalumab Market Size and Growth Rate of 10mL Injection from 2014 to 2026

1.4 Market Segmentation by End-Users

1.4.1 Global Durvalumab Market Size and Growth Rate of Locally Advanced Urothelial Carcinoma from 2014 to 2026
1.4.2 Global Durvalumab Market Size and Growth Rate of Metastatic Urothelial Carcinoma from 2014 to 2026
1.4.3 Global Durvalumab Market Size and Growth Rate of Other from 2014 to 2026

1.5 Market Segmentation by Regions

1.5.1 North America Durvalumab Market Size and Growth Rate from 2014 to 2026

1.5.1.1 United States Durvalumab Market Size and Growth Rate from 2014 to 2026
1.5.1.2 Canada Durvalumab Market Size and Growth Rate from 2014 to 2026
1.5.1.3 Mexico Durvalumab Market Size and Growth Rate from 2014 to 2026

1.5.2 Europe Durvalumab Market Size and Growth Rate from 2014 to 2026

1.5.2.1 Germany Durvalumab Market Size and Growth Rate from 2014 to 2026
1.5.2.2 UK Durvalumab Market Size and Growth Rate from 2014 to 2026
1.5.2.3 France Durvalumab Market Size and Growth Rate from 2014 to 2026
1.5.2.4 Italy Durvalumab Market Size and Growth Rate from 2014 to 2026
1.5.2.5 Nordic Countries Durvalumab Market Size and Growth Rate from 2014 to 2026
1.5.2.6 Spain Durvalumab Market Size and Growth Rate from 2014 to 2026
1.5.2.7 Belgium Durvalumab Market Size and Growth Rate from 2014 to 2026
1.5.2.8 Poland Durvalumab Market Size and Growth Rate from 2014 to 2026
1.5.2.9 Russia Durvalumab Market Size and Growth Rate from 2014 to 2026
1.5.2.10 Turkey Durvalumab Market Size and Growth Rate from 2014 to 2026

1.5.3 Asia-Pacific Durvalumab Market Size and Growth Rate from 2014 to 2026

1.5.3.1 China Durvalumab Market Size and Growth Rate from 2014 to 2026
1.5.3.2 Japan Durvalumab Market Size and Growth Rate from 2014 to 2026
1.5.3.3 Australia and New Zealand Durvalumab Market Size and Growth Rate from 2014 to 2026
1.5.3.4 India Durvalumab Market Size and Growth Rate from 2014 to 2026
1.5.3.5 ASEAN Countries Durvalumab Market Size and Growth Rate from 2014 to 2026
1.5.3.6 South Korea Durvalumab Market Size and Growth Rate from 2014 to 2026

1.5.4 Latin America, Middle East & Africa Durvalumab Market Size and Growth Rate from 2014 to 2026

1.5.4.1 GCC Countries Durvalumab Market Size and Growth Rate from 2014 to 2026
1.5.4.2 Brazil Durvalumab Market Size and Growth Rate from 2014 to 2026
1.5.4.3 Nigeria Durvalumab Market Size and Growth Rate from 2014 to 2026
1.5.4.4 South Africa Durvalumab Market Size and Growth Rate from 2014 to 2026
1.5.4.5 Argentina Durvalumab Market Size and Growth Rate from 2014 to 2026

2 Market Trends and Competitive Landscape

2.1 Market Trends and Dynamics

2.1.1 Market Challenges and Restraints
2.1.2 Market Opportunities and Potentials
2.1.3 Mergers and Acquisitions

2.2 Competitive Landscape Analysis

2.2.1 Industrial Concentration Analysis
2.2.2 Porter's Five Forces Analysis of the Industry
2.2.3 SWOT Analysis for New Entrants

3 Segmentation of Durvalumab Market by Types

3.1 Product Development Trends of Different Types
3.2 Commercial Product Types of Major Vendors
3.3 Competitive Landscape Analysis of Different Types
3.4 Market Size of Durvalumab by Major Types

3.4.1 Durvalumab Market Size and Growth Rate of 24mL Injection
3.4.2 Durvalumab Market Size and Growth Rate of 10mL Injection

4 Segmentation of Durvalumab Market by End-Users

4.1 Downstream Client Analysis by End-Users
4.2 Competitive Landscape Analysis of Different End-Users
4.3 Market Potential Analysis of Different End-Users
4.4 Market Size of Durvalumab by Major End-Users

4.4.1 Market Size and Growth Rate of Durvalumab in Locally Advanced Urothelial Carcinoma
4.4.2 Market Size and Growth Rate of Durvalumab in Metastatic Urothelial Carcinoma
4.4.3 Market Size and Growth Rate of Durvalumab in Other

5 Market Analysis by Major Regions

5.1 Global Durvalumab Production Analysis by Major Regions
5.2 Global Durvalumab Consumption Analysis by Major Regions
5.3 Global Durvalumab Production, Import, Consumption and Export Analysis by Regions

5.3.1 North America Durvalumab Production, Import, Consumption and Export Analysis
5.3.2 Europe Durvalumab Production, Import, Consumption and Export Analysis
5.3.3 Asia Pacific Durvalumab Production, Import, Consumption and Export Analysis
5.3.4 Latin America, Middle East & Africa Durvalumab Production, Import, Consumption and Export Analysis

6 Product Commodity of Durvalumab Market in Major Countries

6.1 Top 5 Export Countries in Durvalumab market from 2014 to 2019

6.1.1 Top 5 Export Countries' Export Value Analysis in Durvalumab market from 2014 to 2019
6.1.2 Top 5 Export Countries' Export Volume Analysis in Durvalumab market from 2014 to 2019

6.2 Top 5 Import Countries in Durvalumab market from 2014 to 2019

6.2.1 Top 5 Import Countries' Import Value Analysis in Durvalumab market from 2014 to 2019
6.2.2 Top 5 Import Countries' Import Volume Analysis in Durvalumab market from 2014 to 2019

6.3 Emerging Top 3 Export Countries Analysis
6.4 Emerging Top 3 Import Countries Analysis

7 North America Durvalumab Landscape Analysis

7.1 North America Durvalumab Landscape Analysis by Major Types
7.2 North America Durvalumab Landscape Analysis by Major End-Users
7.3 North America Durvalumab Landscape Analysis by Major Countries

7.3.1 United States Durvalumab Market Volume and Growth Rate
7.3.2 Canada Durvalumab Market Volume and Growth Rate
7.3.3 Mexico Durvalumab Market Volume and Growth Rate

8 Europe Durvalumab Landscape Analysis

8.1 Europe Durvalumab Landscape Analysis by Major Types
8.2 Europe Durvalumab Landscape Analysis by Major End-Users
8.3 Europe Durvalumab Landscape Analysis by Major Countries

8.3.1 Germany Durvalumab Market Volume and Growth Rate
8.3.2 UK Durvalumab Market Volume and Growth Rate
8.3.3 France Durvalumab Market Volume and Growth Rate
8.3.4 Italy Durvalumab Market Volume and Growth Rate
8.3.5 Nordic Countries Durvalumab Market Volume and Growth Rate
8.3.6 Spain Durvalumab Market Volume and Growth Rate
8.3.7 Belgium Durvalumab Market Volume and Growth Rate
8.3.8 Poland Durvalumab Market Volume and Growth Rate
8.3.9 Russia Durvalumab Market Volume and Growth Rate
8.3.10 Turkey Durvalumab Market Volume and Growth Rate

9 Asia Pacific Durvalumab Landscape Analysis

9.1 Asia Pacific Durvalumab Landscape Analysis by Major Types
9.2 Asia Pacific Durvalumab Landscape Analysis by Major End-Users
9.3 Asia Pacific Durvalumab Landscape Analysis by Major Countries

9.3.1 China Durvalumab Market Volume and Growth Rate
9.3.2 Japan Durvalumab Market Volume and Growth Rate
9.3.3 Australia and New Zealand Durvalumab Market Volume and Growth Rate
9.3.4 India Durvalumab Market Volume and Growth Rate
9.3.5 ASEAN Countries Durvalumab Market Volume and Growth Rate
9.3.6 South Korea Durvalumab Market Volume and Growth Rate

10 Latin America, Middle East & Africa Durvalumab Landscape Analysis

10.1 Latin America, Middle East & Africa Durvalumab Landscape Analysis by Major Types
10.2 Latin America, Middle East & Africa Durvalumab Landscape Analysis by Major End-Users
10.3 Latin America, Middle East & Africa Durvalumab Landscape Analysis by Major Countries

10.3.1 GCC Countries Durvalumab Market Volume and Growth Rate
10.3.2 Brazil Durvalumab Market Volume and Growth Rate
10.3.3 Nigeria Durvalumab Market Volume and Growth Rate
10.3.4 South Africa Durvalumab Market Volume and Growth Rate
10.3.5 Argentina Durvalumab Market Volume and Growth Rate

11 Major Players Profile

11.1 Medimmune (AstraZeneca)

11.1.1 Medimmune (AstraZeneca) Company Profile and Recent Development
11.1.2 Market Performance
11.1.3 Product and Service Introduction

12 Data Source and Research Methodology

The List of Tables and Figures (Totals 102 Figures and 152 Tables)

Figure Product Picture
Figure Durvalumab Market Size and Growth Rate of 24mL Injection from 2014 to 2026
Figure Durvalumab Market Size and Growth Rate of 10mL Injection from 2014 to 2026
Figure Market Share by Type in 2014
Figure Market Share by Type in 2018
Figure Market Share by Type in 2026
Figure Global Durvalumab Market Size and Growth Rate of Locally Advanced Urothelial Carcinoma from 2014 to 2026
Figure Global Durvalumab Market Size and Growth Rate of Metastatic Urothelial Carcinoma from 2014 to 2026
Figure Global Durvalumab Market Size and Growth Rate of Other from 2014 to 2026
Figure Market Share by End-User in 2014
Figure Market Share by End-User in 2018
Figure Market Share by End-User in 2026
Figure North America Durvalumab Consumption Market Size and Growth Rate from 2014 to 2026
Figure United States Durvalumab Consumption Market Size and Growth Rate from 2014 to 2026
Figure Canada Durvalumab Consumption Market Size and Growth Rate from 2014 to 2026
Figure Mexico Durvalumab Consumption Market Size and Growth Rate from 2014 to 2026
Figure Europe Durvalumab Consumption Market Size and Growth Rate from 2014 to 2026
Figure Germany Durvalumab Consumption Market Size and Growth Rate from 2014 to 2026
Figure UK Durvalumab Consumption Market Size and Growth Rate from 2014 to 2026
Figure France Durvalumab Consumption Market Size and Growth Rate from 2014 to 2026
Figure Italy Durvalumab Consumption Market Size and Growth Rate from 2014 to 2026
Figure Nordic Countries Durvalumab Consumption Market Size and Growth Rate from 2014 to 2026
Figure Spain Durvalumab Consumption Market Size and Growth Rate from 2014 to 2026
Figure Belgium Durvalumab Consumption Market Size and Growth Rate from 2014 to 2026
Figure Poland Durvalumab Consumption Market Size and Growth Rate from 2014 to 2026
Figure Russia Durvalumab Consumption Market Size and Growth Rate from 2014 to 2026
Figure Turkey Durvalumab Consumption Market Size and Growth Rate from 2014 to 2026
Figure Asia-Pacific Durvalumab Consumption Market Size and Growth Rate from 2014 to 2026
Figure China Durvalumab Consumption Market Size and Growth Rate from 2014 to 2026
Figure Japan Durvalumab Consumption Market Size and Growth Rate from 2014 to 2026
Figure Australia and New Zealand Durvalumab Consumption Market Size and Growth Rate from 2014 to 2026
Figure India Durvalumab Consumption Market Size and Growth Rate from 2014 to 2026
Figure ASEAN Countries Durvalumab Consumption Market Size and Growth Rate from 2014 to 2026
Figure South Korea Durvalumab Consumption Market Size and Growth Rate from 2014 to 2026
Figure Latin America, Middle East & Africa Durvalumab Consumption Market Size and Growth Rate from 2014 to 2026
Figure GCC Countries Durvalumab Consumption Market Size and Growth Rate from 2014 to 2026
Figure Brazil Durvalumab Consumption Market Size and Growth Rate from 2014 to 2026
Figure Nigeria Durvalumab Consumption Market Size and Growth Rate from 2014 to 2026
Figure South Africa Durvalumab Consumption Market Size and Growth Rate from 2014 to 2026
Figure Argentina Durvalumab Consumption Market Size and Growth Rate from 2014 to 2026
Figure Development Trends and Industry Dynamics of Durvalumab Industry
Figure Market Challenges and Restraints
Figure Market Opportunities and Potentials
Table Mergers and Acquisition
Figure Market Share of TOP 3 Players in 2018
Figure Market Share of TOP 5 Players in 2018
Figure Market Share of TOP 6 Players from 2014 to 2019
Figure Porter's Five Forces Analysis
Figure New Entrant SWOT Analysis
Table Specifications of Different Types of Durvalumab
Figure Development Trends of Different Types
Table Commercial Products Types of Major Vendors
Figure Competitive Landscape Analysis of Different Types
Table Consumption of Durvalumab by Different Types from 2014 to 2026
Table Consumption Share of Durvalumab by Different Types from 2014 to 2026
Figure Market Size and Growth Rate of 24mL Injection
Figure Market Size and Growth Rate of 10mL Injection
Table Downstream Client Analysis by End-Users
Figure Competitive Landscape Analysis of Different End-Users
Table Market Potential Analysis of Different End-Users
Table Consumption of Durvalumab by Different End-Users from 2014 to 2026
Table Consumption Share of Durvalumab by Different End-Users from 2014 to 2026
Figure Market Size and Growth Rate of Locally Advanced Urothelial Carcinoma
Figure Market Size and Growth Rate of Metastatic Urothelial Carcinoma
Figure Market Size and Growth Rate of Other
Table Global Durvalumab Production by Major Regions
Table Global Durvalumab Production Share by Major Regions
Figure Global Durvalumab Production Share by Major Regions in 2014
Figure Global Durvalumab Production Share by Major Regions in 2018
Figure Global Durvalumab Production Share by Major Regions in 2026
Table Global Durvalumab Consumption by Major Regions
Table Global Durvalumab Consumption Share by Major Regions
Figure Global Durvalumab Consumption Share by Major Regions in 2014
Figure Global Durvalumab Consumption Share by Major Regions in 2018
Figure Global Durvalumab Consumption Share by Major Regions in 2026
Table North America Durvalumab Production, Import, Consumption and Export Analysis
Table Europe Durvalumab Production, Import, Consumption and Export Analysis
Table Asia Pacific Durvalumab Production, Import, Consumption and Export Analysis
Table Latin America, Middle East & Africa Durvalumab Production, Import, Consumption and Export Analysis
Table Top 5 Export Countries' Export Value Analysis in Durvalumab market from 2014 to 2019
Table Top 5 Export Countries' Export Volume Analysis in Durvalumab market from 2014 to 2019
Table Top 5 Import Countries' Import Value Analysis in Durvalumab market from 2014 to 2019
Table Top 5 Import Countries' Import Volume Analysis in Durvalumab market from 2014 to 2019
Figure Emerging Top 3 Export Countries Analysis
Figure Emerging Top 3 Import Countries Analysis
Table North America Durvalumab Consumption by Types from 2014 to 2026
Table North America Durvalumab Consumption Share by Types from 2014 to 2026
Figure North America Durvalumab Consumption Share by Types in 2014
Figure North America Durvalumab Consumption Share by Types in 2018
Figure North America Durvalumab Consumption Share by Types in 2026
Table North America Durvalumab Consumption by End-Users from 2014 to 2026
Table North America Durvalumab Consumption Share by End-Users from 2014 to 2026
Figure North America Durvalumab Consumption Share by End-Users in 2014
Figure North America Durvalumab Consumption Share by End-Users in 2018
Figure North America Durvalumab Consumption Share by End-Users in 2026
Table North America Durvalumab Consumption by Major Countries from 2014 to 2026
Table North America Durvalumab Consumption Share by Major Countries from 2014 to 2026
Figure North America Durvalumab Consumption Share by Major Countries in 2014
Figure North America Durvalumab Consumption Share by Major Countries in 2018
Figure North America Durvalumab Consumption Share by Major Countries in 2026
Figure United States Durvalumab Market Volume and Growth Rate from 2014 to 2026
Figure Canada Durvalumab Market Volume and Growth Rate from 2014 to 2026
Figure Mexico Durvalumab Market Volume and Growth Rate from 2014 to 2026
Table Europe Durvalumab Consumption by Types from 2014 to 2026
Table Europe Durvalumab Consumption Share by Types from 2014 to 2026
Figure Europe Durvalumab Consumption Share by Types in 2014
Figure Europe Durvalumab Consumption Share by Types in 2018
Figure Europe Durvalumab Consumption Share by Types in 2026
Table Europe Durvalumab Consumption by End-Users from 2014 to 2026
Table Europe Durvalumab Consumption Share by End-Users from 2014 to 2026
Figure Europe Durvalumab Consumption Share by End-Users in 2014
Figure Europe Durvalumab Consumption Share by End-Users in 2018
Figure Europe Durvalumab Consumption Share by End-Users in 2026
Table Europe Durvalumab Consumption by Major Countries from 2014 to 2026
Table Europe Durvalumab Consumption Share by Major Countries from 2014 to 2026
Figure Europe Durvalumab Consumption Share by Major Countries in 2014
Figure Europe Durvalumab Consumption Share by Major Countries in 2018
Figure Europe Durvalumab Consumption Share by Major Countries in 2026
Figure Germany Durvalumab Market Volume and Growth Rate from 2014 to 2026
Figure UK Durvalumab Market Volume and Growth Rate from 2014 to 2026
Figure France Durvalumab Market Volume and Growth Rate from 2014 to 2026
Figure Italy Durvalumab Market Volume and Growth Rate from 2014 to 2026
Figure Nordic Countries Durvalumab Market Volume and Growth Rate from 2014 to 2026
Figure Belgium Durvalumab Market Volume and Growth Rate from 2014 to 2026
Figure Poland Durvalumab Market Volume and Growth Rate from 2014 to 2026
Figure Russia Durvalumab Market Volume and Growth Rate from 2014 to 2026
Figure Turkey Durvalumab Market Volume and Growth Rate from 2014 to 2026
Table Asia Pacific Durvalumab Consumption by Types from 2014 to 2026
Table Asia Pacific Durvalumab Consumption Share by Types from 2014 to 2026
Figure Asia Pacific Durvalumab Consumption Share by Types in 2014
Figure Asia Pacific Durvalumab Consumption Share by Types in 2018
Figure Asia Pacific Durvalumab Consumption Share by Types in 2026
Table Asia Pacific Durvalumab Consumption by End-Users from 2014 to 2026
Table Asia Pacific Durvalumab Consumption Share by End-Users from 2014 to 2026
Figure Asia Pacific Durvalumab Consumption Share by End-Users in 2014
Figure Asia Pacific Durvalumab Consumption Share by End-Users in 2018
Figure Asia Pacific Durvalumab Consumption Share by End-Users in 2026
Table Asia Pacific Durvalumab Consumption by Major Countries from 2014 to 2026
Table Asia Pacific Durvalumab Consumption Share by Major Countries from 2014 to 2026
Figure Asia Pacific Durvalumab Consumption Share by Major Countries in 2014
Figure Asia Pacific Durvalumab Consumption Share by Major Countries in 2018
Figure Asia Pacific Durvalumab Consumption Share by Major Countries in 2026
Figure China Durvalumab Market Volume and Growth Rate from 2014 to 2026
Figure Japan Durvalumab Market Volume and Growth Rate from 2014 to 2026
Figure Australia and New ZealandDurvalumab Market Volume and Growth Rate from 2014 to 2026
Figure India Durvalumab Market Volume and Growth Rate from 2014 to 2026
Figure ASEAN Countries Durvalumab Market Volume and Growth Rate from 2014 to 2026
Figure South Korea Durvalumab Market Volume and Growth Rate from 2014 to 2026
Table Latin America, Middle East & Africa Durvalumab Consumption by Types from 2014 to 2026
Table Latin America, Middle East & Africa Durvalumab Consumption Share by Types from 2014 to 2026
Figure Latin America, Middle East & Africa Durvalumab Consumption Share by Types in 2014
Figure Latin America, Middle East & Africa Durvalumab Consumption Share by Types in 2018
Figure Latin America, Middle East & Africa Durvalumab Consumption Share by Types in 2026
Table Latin America, Middle East & Africa Durvalumab Consumption by End-Users from 2014 to 2026
Table Latin America, Middle East & Africa Durvalumab Consumption Share by End-Users from 2014 to 2026
Figure Latin America, Middle East & Africa Durvalumab Consumption Share by End-Users in 2014
Figure Latin America, Middle East & Africa Durvalumab Consumption Share by End-Users in 2018
Figure Latin America, Middle East & Africa Durvalumab Consumption Share by End-Users in 2026
Table Latin America, Middle East & Africa Durvalumab Consumption by Major Countries from 2014 to 2026
Table Latin America, Middle East & Africa Durvalumab Consumption Share by Major Countries from 2014 to 2026
Figure Latin America, Middle East & Africa Durvalumab Consumption Share by Major Countries in 2014
Figure Latin America, Middle East & Africa Durvalumab Consumption Share by Major Countries in 2018
Figure Latin America, Middle East & Africa Durvalumab Consumption Share by Major Countries in 2026
Figure GCC Countries Durvalumab Market Volume and Growth Rate from 2014 to 2026
Figure Brazil Durvalumab Market Volume and Growth Rate from 2014 to 2026
Figure Nigeria Durvalumab Market Volume and Growth Rate from 2014 to 2026
Figure South Africa Durvalumab Market Volume and Growth Rate from 2014 to 2026
Figure Argentina Durvalumab Market Volume and Growth Rate from 2014 to 2026
Table Company Profile and Development Status of Medimmune (AstraZeneca)
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Medimmune (AstraZeneca)
Figure Sales and Growth Rate Analysis of Medimmune (AstraZeneca)
Figure Revenue and Market Share Analysis of Medimmune (AstraZeneca)
Table Product and Service Introduction of Medimmune (AstraZeneca)

REPORTS

Let’s Pullulate and Expand Your Business